Previous close | 0.3200 |
Open | 0.3400 |
Bid | 0.0000 |
Ask | 0.0000 |
Strike | 90.00 |
Expiry date | 2024-06-21 |
Day's range | 0.3100 - 0.3500 |
Contract range | N/A |
Volume | |
Open interest | 2.1k |
Abbott Laboratories (ABT) reported first quarter results that topped Wall Street estimates on both the top and bottom lines. The healthcare products company also raised the lower end of its full-year earnings guidance range. Yahoo Finance's Anjalee Khemlani breaks down the results in the video above. For more expert insight and the latest market action, click here to watch this full episode of Morning Brief. This post was written by Stephanie Mikulich.
Abbott Laboratories ( NYSE:ABT ) First Quarter 2024 Results Key Financial Results Revenue: US$9.96b (up 2.2% from 1Q...
Abbott Laboratories reports robust Q1 performance with significant sales growth and upward revisions in annual forecasts.